Pfizer vaccine was received by the majority (1st dose n=204, 76%) of the study sample and an increasing trend in choice of Pfizer was observed at 80% and 84% in 2nd and 3rd doses respectively.
← all excerpts
Analyzing COVID-19 Vaccination Side Effects Among the Adult Population in Jeddah, Saudi Arabia.
1
—
—